相关实验视频
Updated: Jun 28, 2025
08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
16.2K
在患有功能障碍的患者中,铁代谢和炎症媒介
Tomomi Matsuoka1, Masanori Abe1, Hiroki Kobayashi1
1Division of Nephrology, Hypertension and Endocrinology, Department of Medicine, Nihon University School of Medicine, Tokyo 173-8610, Japan.
International journal of molecular sciences
|April 13, 2024
概括
慢性病 (CKD) 涉及铁代谢和炎症之间的复杂相互作用,导致贫血. 了解这些联系对于开发更好的CKD患者治疗方法至关重要.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
背景情况:
- 慢性病 (CKD) 影响全球8.5亿人,导致贫血和心血管疾病等并发症.
- 慢性病中的贫血源于红色素减少 (EPO) 和铁失调,由疾病进展恶化.
- 尿液毒素和炎症在慢性病患者中显著破坏铁代谢和红色素形成.
研究的目的:
- 审查CKD中铁代谢,炎症和功能障碍之间的复杂相互作用.
- 突出尿素毒素和炎症性细胞因子导致脏贫血的机制.
- 讨论当前和新兴的治疗策略来管理CKD相关的贫血.
主要方法:
- 关于CKD,铁代谢,炎症和贫血的研究的文献综述.
- 分析尿素毒素 (例如,硫酸) 和细胞因子 (例如,TNF-α,IL-6) 在CKD病理生理学的作用.
- 检查当前和新型治疗方法,包括EPO,铁疗法,肝素向和HIF稳定剂.
主要成果:
- 缺铁 (绝对和功能性) 是CKD贫血的主要原因,由炎症和吸收受损加剧.
- 尿素毒素如硫酸直接损害脏EPO合成,并导致缺氧,恶化贫血.
- 炎症性细胞因子 (TNF-α,IL-6) 加快CKD的进展并破坏铁的平衡,增加贫血的严重程度.
结论:
- 针对铁,EPO,炎症和尿素毒素的综合治疗策略对于改善CKD患者的治疗结果至关重要.
- 针对肝素和利用缺氧诱导因子 (HIF) 稳定剂的新兴疗法在治疗慢性病相关贫血方面表现有前途.
- 进一步研究铁代谢,炎症和功能障碍之间的复杂关系对于推进CKD护理至关重要.
相关概念视频
01:11Renal Failure: Dose Adjustments
88
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
88
01:17Factors Affecting Renal Clearance: Renal Impairment
91
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
91
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
81
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
81
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
01:25Antihypertensive Drugs: Direct Renin Inhibitors
613
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
613
01:20Renal Corpuscle
2.0K
The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
2.0K